Medicines used in children against cough and cold: review of the risk-benefit balance and new measures

The Committee for Medicinal Products for Human Use has reassessed the risk-benefit balance of medicines used in children against cough and cold, namely antitussives, expectorants and topical nasal decongestants. Based on the advice of this commission, the Federal Agency for Medicines and Health Products (FAMHP) has taken certain measures concerning these medicines.

See other languages: French or Dutch.



Last updated on 02/04/2012